Skip to main content
Fig. 5 | Lipids in Health and Disease

Fig. 5

From: A novel self-micro-emulsifying delivery system (SMEDS) formulation significantly improves the fasting absorption of EPA and DHA from a single dose of an omega-3 ethyl ester concentrate

Fig. 5

Baseline-corrected EPA and DHA concentration in plasma over time. Average value of baseline-corrected EPA and DHA concentration in plasma after a single oral dose of PRF-021 formulated Omega-3 EE or control Omega-3 EE up to 48 h with standard error bar (a) low dose Study 1, EPA, N = 20; (b) high dose Study 2, EPA, N = 39 for PRF-021 and N = 40 for Control; (c) low dose Study 1, DHA, N = 20 and (d) high dose Study 2, DHA, N = 39 for PRF-021 and N = 40 for Control

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X